| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 213 | 2023 |
| NCCN Guidelines® insights: genetic/familial high-risk assessment: colorectal, Version 1.2021: featured updates to the NCCN Guidelines JM Weiss, S Gupta, CA Burke, L Axell, LM Chen, DC Chung, ... Journal of the National Comprehensive Cancer Network 19 (10), 1122-1132, 2021 | 126 | 2021 |
| Locoregional and systemic therapy for hepatocellular carcinoma OB Gbolahan, MA Schacht, EW Beckley, TP LaRoche, BH O’Neil, M Pyko Journal of gastrointestinal oncology 8 (2), 215, 2017 | 96 | 2017 |
| Germline and somatic DNA damage repair gene mutations and overall survival in metastatic pancreatic adenocarcinoma patients treated with FOLFIRINOX A Sehdev, O Gbolahan, BA Hancock, M Stanley, S Shahda, J Wan, ... Clinical Cancer Research 24 (24), 6204-6211, 2018 | 74 | 2018 |
| A phase II study of pemetrexed in patients with recurrent thymoma and thymic carcinoma OB Gbolahan, RF Porter, JT Salter, C Yiannoutsos, M Burns, EG Chiorean, ... Journal of Thoracic Oncology 13 (12), 1940-1948, 2018 | 51 | 2018 |
| Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label … JH Strickler, A Cercek, S Siena, T André, K Ng, E Van Cutsem, C Wu, ... The Lancet Oncology 24 (5), 496-508, 2023 | 48 | 2023 |
| Road safety practices among commercial motorcyclists in a rural town in Nigeria: implications for health education OE Amoran, E Owoaje, G OA, Gbolahan OB Community Health Equity Research & Equity 24 (1), 55-64, 2004 | 48 | 2004 |
| Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE) GR Williams, KM Kenzik, M Parman, M Al-Obaidi, L Francisco, ... Journal of geriatric oncology 11 (2), 270-273, 2020 | 44 | 2020 |
| Amplification of TGFβ induced ITGB6 gene transcription may promote pulmonary fibrosis AL Tatler, AT Goodwin, O Gbolahan, G Saini, J Porte, AE John, RL Clifford, ... PloS one 11 (8), e0158047, 2016 | 44 | 2016 |
| Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study OB Gbolahan, Y Tong, A Sehdev, B O’Neil, S Shahda BMC cancer 19, 1-9, 2019 | 39 | 2019 |
| Immunotherapeutic concepts to target acute myeloid leukemia: focusing on the role of monoclonal antibodies, hypomethylating agents and the leukemic microenvironment OB Gbolahan, AM Zeidan, M Stahl, M Abu Zaid, S Farag, S Paczesny, ... International Journal of Molecular Sciences 18 (8), 1660, 2017 | 32 | 2017 |
| Association of malnutrition with geriatric assessment impairments and health‐related quality of life among older adults with gastrointestinal malignancies GR Williams, M Al‐Obaidi, C Dai, N Mir, SA Challa, M Daniel, H Patel, ... Cancer 126 (23), 5147-5155, 2020 | 30 | 2020 |
| Association between chronologic age and geriatric assessment–identified impairments: findings from the CARE Registry S Giri, M Al-Obaidi, A Weaver, KM Kenzik, A McDonald, D Clark, ... Journal of the National Comprehensive Cancer Network 19 (8), 922-927, 2021 | 25 | 2021 |
| Update on systemic therapy for colorectal cancer: biologics take sides O Gbolahan, B O’Neil Translational Gastroenterology and Hepatology 4, 2019 | 25 | 2019 |
| Depression among older adults with gastrointestinal malignancies RC Godby, C Dai, M Al-Obaidi, S Giri, C Young-Smith, K Kenzik, ... Journal of geriatric oncology 12 (4), 599-604, 2021 | 20 | 2021 |
| Oncology practice in the COVID-19 pandemic: a report of a Nigerian expert panel discussion (oncology care in Nigeria during the COVID-19 pandemic) AA Olabumuyi, M Ali-Gombe, OA Biyi-Olutunde, O Gbolahan, C Iwuji, ... Pan African Medical Journal 36 (1), 2020 | 20 | 2020 |
| Patient-reported cognitive complaints in older adults with gastrointestinal malignancies at diagnosis–Results from the Cancer & Aging Resilience Evaluation (CARE) study N Mir, P MacLennan, M Al-Obaidi, D Murdaugh, KM Kenzik, A McDonald, ... Journal of geriatric oncology 11 (6), 982-988, 2020 | 20 | 2020 |
| Prolonged response to anti–PD-1 antibody therapy in chemotherapy-refractory cholangiocarcinoma with high tumor mutational burden O Gbolahan, N Hashemi-Sadraei, B O’Neil Journal of the National Comprehensive Cancer Network 17 (6), 644-648, 2019 | 20 | 2019 |
| A phase I/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients (Pts) with advanced biliary tract cancers. MM Javle, JA Bridgewater, OB Gbolahan, C Jungels, MT Cho, ... Journal of Clinical Oncology 39 (3_suppl), 311-311, 2021 | 19 | 2021 |
| Clinical characteristics of patients experiencing pathologic complete response following neoadjuvant therapy for borderline resectable/locally advanced pancreatic adenocarcinoma N Hashemi-Sadraei, OB Gbolahan, H Salfity, B O’Neil, MG House, ... American journal of clinical oncology 41 (10), 982-985, 2018 | 19 | 2018 |
